@neurocarrus.com
Neurocarrus is developing a novel drug and delivery technology to treat chronic pain without addiction or disruption of muscular control.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
JPEG
About
Description
Neurocarrus is a biotechnology company at the forefront of transforming pain treatment. With a focus on developing a groundbreaking drug technology, Neurocarrus aims to disrupt pain signals safely and effectively, without the risk of addiction or other systemic effects. Their innovative approach involves targeted delivery of bacterial proteins to modify the skeleton of sensory nerve cells, blocking signaling and providing relief from pain.
Unlike existing FDA-approved proteins in the market, Neurocarrus' technology specifically targets sensory nerves, leaving motor nerves untouched. This approach not only addresses the unmet need for a safe and specific treatment for pain but also contributes to combatting the opioid crisis. With their flagship therapeutic product, N-001, Neurocarrus seeks to improve the lives of millions of individuals suffering from pain, enabling increased mobility and improved life quality.
In addition to pain treatment, Neurocarrus is also exploring the delivery of other drugs for nerve regeneration and nerve fiber imaging as a surgical adjunct. Headquartered in Monterey/Santa Cruz, CA, Neurocarrus is led by an experienced team of research scientists, biotechnology experts, and medical professionals, backed by extensive in vitro and in vivo data supporting the efficacy of N-001. Neurocarrus' mission is to provide a safe and effective solution for pain management, enhancing human health while avoiding systemic side effects
Company Type
Privately Held
Company Size
2-10
Year Founded
2015
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories